The report “Bioresorbable Polymers Market by Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone) PCL), Application (Orthopedic Devices, Drug Delivery), and Region – Global Forecast to 2029″, size was USD 500.0 million in 2024 and is projected to reach USD 867.2 million by 2029, at a CAGR of 11.6%, between 2024 and 2029. The drug delivery segment is the rapidly growing segment for bioresorbable polymers market. The growth is driven by the high demand of oral capsules. Such polymers have long been employed in the design of implantable matrices for effective drug delivery, especially after encapsulation; nontoxicity associated with such absorption makes these systems safe and convenient. Bioresorbable polymers are helping FDA-approved drugs attain better pharmacokinetics by releasing the prescribed drug dosage in a sustained manner, thus eliminating multiple injections or surgical means of drug delivery. These polymers integrate out of function and are absorbed into the body after their use, making it more comfortable and favorable for patients to use, which is driving demand in this segment.
Browse
• 257 Market data Tables
• 58 Figures
• 221 Pages and in-depth TOC on “Bioresorbable Polymers Market – Global Forecast to 2029″
• 58 Figures
• 221 Pages and in-depth TOC on “Bioresorbable Polymers Market – Global Forecast to 2029″
Some of the prominent key players are:
- Corbion (Netherlands),
- Evonik Industries AG (Germany),
- Foster Corporation (US),
- KLS Martin Group (Germany),
- DSM Biomedical (US),
- Ashland Global Holdings Inc. (US), and many more….
Opportunity: Electrospinning and 3D printing technology
Bioresorbable polymers, particularly in the case of electrospinning combined with 3D printing, are improving scaffold fabrication in tissue engineering in that scaffolds are more biocompatible and supportive to cells. Electrospinning produces thin fibrous elements representing the structure of the natural extracellular matrix (ECM) in order to enhance the cell attachment and growth required for the formation of the desired tissue. 3D printing also makes it possible to produce scaffolds as per specific patient needs, optimized according to the required dimensions, configurations, and biodegradation rates, which are important for regenerative medicine. The architecture of the detailed scaffold design enhances the tissue integration capacity, more so in the repair of bone and soft tissues. Because these polymers are designed to erode away in the body, the chances of the patient undergoing a removal surgery are significantly reduced, thus breathing new life into personalized medicine and creative treatment approaches.
PLA by type is estimated to be the largest type of bioresorbable polymers market, in terms of value, during the forecast period.
The PLA type segment is estimated to be largest type segment in the bioresorbable polymers market, in terms of value, during the forecast period. PLA has been of great use in orthopedic devices and drug delivery systems because of its biodegradability and bioresorbability. Use of PLA-based bioresorbable implants offers temporary structural support in orthopedic applications, allowing natural tissue regeneration to occur and thus eliminating the necessity of removal surgically. In drug delivery, PLA is used in controlled release systems, where it enables the precise delivery of medication directly to the body and eventually dissolves without leaving residues. With compatibility of PLA to human tissue and the possibility of engineering it to suit specific medical purposes, this material also supports the wide use in healthcare settings as the need grows for patient-centered, minimally invasive solutions. This growth is further driven by increasing medical awareness and government support for advanced biocompatible materials.
South America is projected to register the second highest CAGR, in terms of value, during the forecast period in the bioresorbable polymers market.
South America is projected to register the second highest CAGR in the bioresorbable polymers market, in terms of value, during forecast period due to several factors. Continued research and development in manufacturing technology in the South American market influences the bioresorbable polymers market. Innovative solutions that increase functionality, reduce costs, and improve product quality must be developed as industries involve. This includes developments in medical device manufacturing techniques and new materials, such as biocompatible polymers.
